Search

Author/Creator Simon, Jason

3. Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. Issue 2 (December 2015)

Authors:
Sznol, Mario; Fishman, Mayer; Escudier, Bernard; McDermott, David; Kluger, Harriet; Stadler, Walter; Perez-Gracia, Jose; McNeel, Douglas; Curti, Brendan; Harrison, Michael; Plimack, Elizabeth; Appleman, Leonard; Fong, Lawrence; Drake, Charles; Young, Tina; Chasalow, Scott; Ross-MacDonald, Petra; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032. Issue 2 (December 2015)

Authors:
Taylor, Matthew; Antonia, Scott; Bendell, Johanna; Calvo, Emiliano; Jäger, Dirk; de Braud, Filippo; Ott, Patrick; Pietanza, M; Horn, Leora; Le, Dung; Morse, Michael; López-Martin, José; Ascierto, Paolo; Christensen, Olaf; Simon, Jason; Lin, Chen-Sheng; Eder, Joseph
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗